Biotechnology Biosplice Announces Upcoming Presentation of Successful OA-07 Phase 3 Long-Term Structure and Pain & Function Results for Lorecivivint for Treatment of Knee Osteoarthritis at OARSI Conference, and Completion and Preliminary Analysis of OA-21 Trial 12-Week Pain Results Read more
Biotechnology Surrozen Announces Safety, Pharmacodynamic and Liver Function Data for SZN-043 – Surrozen (NASDAQ:SRZN) Read more
Biotechnology Biogen’s Spinraza For Muscle Movement Disorder Shows Improved Motor Function In Infants, Toddlers – Biogen (NASDAQ:BIIB) Read more
Eurozone Spain’s Medical Marijuana Law To Function Soon, First Cannabis Club In Malta & More Euro Weed Updates Read more